[HYGIENIC ASSESSMENT OF THE LIPID COMPONENT IN THE STRUCTURE OF NUTRITION OF STUDENT YOUNG ADULTS].

The actual nutrition of the Omsk University students aged 18-27 years, was studied with the use of the method of the analysis of the frequency of food consumption. There is done quantitative assessment of nutrient consumption related to the fat component of food. There is described the qualitative composition of lipids and its effect on indices of the nutritional status assessed with the use of somatometric, bioelectric impedance and laboratory methods. The nutrition of students is established to be irrational, unbalanced on the lipid component and creates conditions for the formation of diseases with alimentary dietary risk factors. Traditional indices of nutritional status (BMI, W/HR) at this are within the boundaries of normal values, but the composition of the body under the influence of an excess of animal fats with a deficiency of essential polyunsaturated fatty acids is altering that can be diagnosed with the aid of bioimpedance measuring method. There are established correlation relations between the parameters ofconsumption of dietary lipids and indices of the nutritional status in young adults.

A phase II study of i.v. methylprednisolone in secondary-progressive multiple sclerosis.

OBJECTIVE: To compare the tolerability and efficacy of two doses of i.v. methylprednisolone in patients with secondary-progressive MS. METHODS: I.v. methylprednisolone administered in high or low dose every other month for up to 2 years to 108 patients with secondary-progressive MS. RESULTS: No significant difference in efficacy with the primary outcome, a comparison of the proportions of patients in each treatment group who experienced sustained progression of disability. A relative treatment effect was detected with the high-dose regimen as measured by the preplanned secondary analysis, a comparison of time to onset of sustained progression of disability. Drug-related adverse events were observed more frequently in high-dose recipients but serious drug-related adverse events were uncommon, and cessation of study drug was only required in one patient. CONCLUSION: The results of the secondary analysis of this study suggest that a phase III trial of corticosteroids for secondary-progressive MS is warranted.